Truist Financial Forecasts Strong Price Appreciation for Sabra Healthcare REIT (NASDAQ:SBRA) Stock

Sabra Healthcare REIT (NASDAQ:SBRA) had its target price raised by investment analysts at Truist Financial from $22.00 to $24.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the real estate investment trust’s stock. Truist Financial’s price objective points to a potential upside of 9.16% from the company’s current price.

Other equities research analysts have also issued research reports about the company. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Sabra Healthcare REIT in a research note on Wednesday. Barclays started coverage on shares of Sabra Healthcare REIT in a research note on Tuesday, July 7th. They set an “overweight” rating and a $21.00 price objective on the stock. Wells Fargo & Company boosted their target price on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a research report on Monday, June 1st. Cantor Fitzgerald upped their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Monday, May 11th. Finally, Weiss Ratings lowered shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a report on Thursday, June 4th. Eight research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Sabra Healthcare REIT currently has an average rating of “Moderate Buy” and an average price target of $22.25.

Sabra Healthcare REIT Trading Down 0.2%

NASDAQ SBRA traded down $0.05 during mid-day trading on Wednesday, hitting $21.99. The company’s stock had a trading volume of 2,037,666 shares, compared to its average volume of 2,769,527. The firm has a market capitalization of $5.54 billion, a P/E ratio of 34.99, a price-to-earnings-growth ratio of 1.49 and a beta of 0.65. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72. Sabra Healthcare REIT has a 52-week low of $17.17 and a 52-week high of $22.55. The stock’s fifty day simple moving average is $19.61 and its two-hundred day simple moving average is $19.78.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.16. The company had revenue of $211.74 million during the quarter, compared to analyst estimates of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The business’s quarterly revenue was up 20.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Research analysts expect that Sabra Healthcare REIT will post 1.5 EPS for the current year.

Institutional Investors Weigh In On Sabra Healthcare REIT

Hedge funds and other institutional investors have recently modified their holdings of the stock. Focus Partners Wealth grew its stake in Sabra Healthcare REIT by 11.4% in the first quarter. Focus Partners Wealth now owns 23,146 shares of the real estate investment trust’s stock worth $404,000 after purchasing an additional 2,375 shares in the last quarter. EverSource Wealth Advisors LLC grew its position in shares of Sabra Healthcare REIT by 150.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock worth $47,000 after acquiring an additional 1,536 shares in the last quarter. First Trust Advisors LP grew its position in shares of Sabra Healthcare REIT by 27.2% in the 2nd quarter. First Trust Advisors LP now owns 368,383 shares of the real estate investment trust’s stock worth $6,793,000 after acquiring an additional 78,709 shares in the last quarter. Cerity Partners LLC increased its holdings in shares of Sabra Healthcare REIT by 73.0% in the 2nd quarter. Cerity Partners LLC now owns 18,686 shares of the real estate investment trust’s stock valued at $345,000 after acquiring an additional 7,885 shares during the last quarter. Finally, Daiwa Securities Group Inc. increased its holdings in shares of Sabra Healthcare REIT by 3.1% in the 2nd quarter. Daiwa Securities Group Inc. now owns 83,889 shares of the real estate investment trust’s stock valued at $1,547,000 after acquiring an additional 2,557 shares during the last quarter. Institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.